Eurofins Scientific SE Statistics

Total Valuation

Eurofins Scientific SE has a market cap or net worth of GBP 7.68 billion. The enterprise value is 10.15 billion.

Market Cap	7.68B
Enterprise Value	10.15B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Jul 3, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-1.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	124.89M

Valuation Ratios

The trailing PE ratio is 27.81.

PE Ratio	27.81
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.22, with an EV/FCF ratio of 16.02.

EV / Earnings	36.74
EV / Sales	1.79
EV / EBITDA	8.22
EV / EBIT	14.63
EV / FCF	16.02

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.67.

Current Ratio	1.42
Quick Ratio	1.20
Debt / Equity	0.67
Debt / EBITDA	2.43
Debt / FCF	4.74
Interest Coverage	5.80

Financial Efficiency

Return on equity (ROE) is 7.27% and return on invested capital (ROIC) is 5.97%.

Return on Equity (ROE)	7.27%
Return on Assets (ROA)	4.85%
Return on Capital (ROIC)	5.97%
Revenue Per Employee	92,245
Profits Per Employee	4,471
Employee Count	61,798
Asset Turnover	0.64
Inventory Turnover	35.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.46%
50-Day Moving Average	47.44
200-Day Moving Average	51.59
Relative Strength Index (RSI)	53.78
Average Volume (20 Days)	34,288

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eurofins Scientific SE had revenue of GBP 5.70 billion and earned 276.30 million in profits. Earnings per share was 1.41.

Revenue	5.70B
Gross Profit	1.26B
Operating Income	695.21M
Pretax Income	427.81M
Net Income	276.30M
EBITDA	1.11B
EBIT	695.21M
Earnings Per Share (EPS)	1.41

Full Income Statement

Balance Sheet

The company has 577.53 million in cash and 3.00 billion in debt, giving a net cash position of -2.43 billion.

Cash & Cash Equivalents	577.53M
Total Debt	3.00B
Net Cash	-2.43B
Net Cash Per Share	n/a
Equity (Book Value)	4.49B
Book Value Per Share	18.80
Working Capital	654.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -396.44 million, giving a free cash flow of 633.75 million.

Operating Cash Flow	1.03B
Capital Expenditures	-396.44M
Free Cash Flow	633.75M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.19%, with operating and profit margins of 12.20% and 5.64%.

Gross Margin	22.19%
Operating Margin	12.20%
Pretax Margin	7.50%
Profit Margin	5.64%
EBITDA Margin	19.45%
EBIT Margin	12.20%
FCF Margin	11.12%

Dividends & Yields

Eurofins Scientific SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-50.58%
Years of Dividend Growth	n/a
Payout Ratio	59.30%
Buyback Yield	0.86%
Shareholder Yield	0.86%
Earnings Yield	3.60%
FCF Yield	8.25%

Dividend Details

Stock Splits

The last stock split was on November 19, 2020. It was a forward split with a ratio of 10.

Last Split Date	Nov 19, 2020
Split Type	Forward
Split Ratio	10

Scores

Eurofins Scientific SE has an Altman Z-Score of 2.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.45
Piotroski F-Score	n/a